Companies › IVVD

INVIVYD INC (IVVD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001832038 · EDGAR filings · Updated 2026-07-28

INVIVYD INC (IVVD) has reported institutional ownership of 76.9%, with 140 institutional managers holding positions valued at $294.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — SCHEDULE 13G filed
• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-06 — Current report (8-K) filed
• 2026-05-21 — Insider transaction reported (Form 4)
• 2026-05-21 — Insider transaction reported (Form 4)
• 2026-05-21 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INVIVYD INC has 140 institutional holders and institutional ownership of 76.9%.

Insider activity

Insiders reported 31 transactions (1 buys, 20 sells) across 6 reporting insiders, with a net reported value of −$396.7K.

Data flags from SEC filings

Related companies

LENZ THERAPEUTICS INC (LENZ) · KYVERNA THERAPEUTICS INC (KYTX) · AQUESTIVE THERAPEUTICS INC (AQST) · FULGENT GENETICS INC (FLGT) · CERUS CORP (CERS) · CORMEDIX INC (CRMD)